HYDROXYCHLOROQUINE FOR THE TREATMENT OF SEVERE RESPIRATORY INFECTION BY COVID-19: A RANDOMIZED CONTROLLED TRIAL

Carmen Hernandez-Cardenas, Ireri Thirion-Romero, Norma E. Rivera-Martinez, Patricia Meza-Meneses, Arantxa Remigio-Luna, Rogelio Perez-Padilla on behalf of the Research Group on hydroxychloroquine for COVID-19
doi: https://doi.org/10.1101/2021.02.01.21250371

Article usage

Article usage: February 2021 to July 2025

AbstractFullPdf
Feb 2021172016340
Mar 202158154120
Apr 20212342466
May 20212551471
Jun 20216985180
Jul 20211532040
Aug 20211742739
Sep 20211623262
Oct 20211751140
Nov 20211221042
Dec 20211321228
Jan 20221761421
Feb 2022126517
Mar 20229187
Apr 202293214
May 202277521
Jun 2022832135
Jul 2022992128
Aug 202277882
Sep 202275552
Oct 202249432
Nov 20223476
Dec 20223969
Jan 20233789
Feb 202355720
Mar 20232753
Apr 202344614
May 202329610
Jun 20232568
Jul 202338210
Aug 2023261411
Sep 202337105
Oct 202326610
Nov 20233856
Dec 20232839
Jan 20242715
Feb 202438415
Mar 20243075
Apr 202425412
May 20242164
Jun 202430220
Jul 20242586
Aug 2024411020
Sep 202447213
Oct 202452511
Nov 202451919
Dec 20243229
Jan 202540313
Feb 2025341913
Mar 2025581716
Apr 202529412
May 2025391115
Jun 2025541212
Jul 202534107
Back to top
Posted February 05, 2021.
Download PDF
Data/Code
Email
HYDROXYCHLOROQUINE FOR THE TREATMENT OF SEVERE RESPIRATORY INFECTION BY COVID-19: A RANDOMIZED CONTROLLED TRIAL
Carmen Hernandez-Cardenas, Ireri Thirion-Romero, Norma E. Rivera-Martinez, Patricia Meza-Meneses, Arantxa Remigio-Luna, Rogelio Perez-Padilla
medRxiv 2021.02.01.21250371; doi: https://doi.org/10.1101/2021.02.01.21250371
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area